HBsAg sT123N mutation induces stronger antibody responses to HBsAg and HBcAg and accelerates in vivo HBsAg clearance. 2015

Songxia Li, and Kaitao Zhao, and Shuhui Liu, and Chunchen Wu, and Yongxuan Yao, and Liang Cao, and Xue Hu, and Yuan Zhou, and Yun Wang, and Rongjuan Pei, and Mengji Lu, and Xinwen Chen
State Key Lab of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.

Immune escape mutants with mutations in the hepatitis B surface antigen (HBsAg) major hydrophilic region (MHR) often emerge in association with diagnostic failure or breakthrough of HBV infection in patients with anti-HBs antibodies. Some mutants harboring substitutions to Asn in HBsAg MHR may have an additional potential N-glycosylation site. We have previously showed that sT123N substitution could generate additional N-glycosylated forms of HBsAg. In the present study, 1.3-fold-overlength HBV genomes containing the sT123N substitution were digested from the pHBV1.3-sT123N construct and subcloned into the pAAV vector to generate pAAV1.3-sT123N for hydrodynamic injection (HI) in mice. Viral expression and replication were phenotypically characterized by transient transfection. The results demonstrated that sT123N substitution impaired virion secretion, resulting in intracellular retention of HBcAg. Using the HBV HI mouse model, we found that mice mounted significantly stronger antibody responses to HBsAg and HBcAg, which accelerated HBsAg clearance. Thus, additional N-glycosylation generated by amino acid substitutions in HBsAg MHR may significantly modulate specific host immune responses and influence HBV infection in vivo. Our results help further the understanding of the role of immune escape mutants with N-linked glycosylation in the biology of HBV infection.

UI MeSH Term Description Entries
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006512 Hepatitis B Core Antigens The hepatitis B antigen within the core of the Dane particle, the infectious hepatitis virion. HBcAg,Hepatitis B Core Antigen
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody

Related Publications

Songxia Li, and Kaitao Zhao, and Shuhui Liu, and Chunchen Wu, and Yongxuan Yao, and Liang Cao, and Xue Hu, and Yuan Zhou, and Yun Wang, and Rongjuan Pei, and Mengji Lu, and Xinwen Chen
June 1985, Zhonghua yi xue za zhi,
Songxia Li, and Kaitao Zhao, and Shuhui Liu, and Chunchen Wu, and Yongxuan Yao, and Liang Cao, and Xue Hu, and Yuan Zhou, and Yun Wang, and Rongjuan Pei, and Mengji Lu, and Xinwen Chen
August 2013, Hepatobiliary & pancreatic diseases international : HBPD INT,
Songxia Li, and Kaitao Zhao, and Shuhui Liu, and Chunchen Wu, and Yongxuan Yao, and Liang Cao, and Xue Hu, and Yuan Zhou, and Yun Wang, and Rongjuan Pei, and Mengji Lu, and Xinwen Chen
January 2010, Immunology and cell biology,
Songxia Li, and Kaitao Zhao, and Shuhui Liu, and Chunchen Wu, and Yongxuan Yao, and Liang Cao, and Xue Hu, and Yuan Zhou, and Yun Wang, and Rongjuan Pei, and Mengji Lu, and Xinwen Chen
January 2017, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology,
Songxia Li, and Kaitao Zhao, and Shuhui Liu, and Chunchen Wu, and Yongxuan Yao, and Liang Cao, and Xue Hu, and Yuan Zhou, and Yun Wang, and Rongjuan Pei, and Mengji Lu, and Xinwen Chen
January 2015, PloS one,
Songxia Li, and Kaitao Zhao, and Shuhui Liu, and Chunchen Wu, and Yongxuan Yao, and Liang Cao, and Xue Hu, and Yuan Zhou, and Yun Wang, and Rongjuan Pei, and Mengji Lu, and Xinwen Chen
May 1989, Journal of clinical pathology,
Songxia Li, and Kaitao Zhao, and Shuhui Liu, and Chunchen Wu, and Yongxuan Yao, and Liang Cao, and Xue Hu, and Yuan Zhou, and Yun Wang, and Rongjuan Pei, and Mengji Lu, and Xinwen Chen
July 1981, Journal of clinical & laboratory immunology,
Songxia Li, and Kaitao Zhao, and Shuhui Liu, and Chunchen Wu, and Yongxuan Yao, and Liang Cao, and Xue Hu, and Yuan Zhou, and Yun Wang, and Rongjuan Pei, and Mengji Lu, and Xinwen Chen
September 2023, Vaccines,
Songxia Li, and Kaitao Zhao, and Shuhui Liu, and Chunchen Wu, and Yongxuan Yao, and Liang Cao, and Xue Hu, and Yuan Zhou, and Yun Wang, and Rongjuan Pei, and Mengji Lu, and Xinwen Chen
September 2008, Poultry science,
Songxia Li, and Kaitao Zhao, and Shuhui Liu, and Chunchen Wu, and Yongxuan Yao, and Liang Cao, and Xue Hu, and Yuan Zhou, and Yun Wang, and Rongjuan Pei, and Mengji Lu, and Xinwen Chen
April 1994, Liver,
Copied contents to your clipboard!